B&L expands offering
Bausch & Lomb has announced a joint venture with femtosecond laser developer 20/10 Perfect Vision, which will allow B&L to offer surgeons the complete 'all laser' refractive solution.
Bausch & Lomb has announced a joint venture with femtosecond laser developer 20/10 Perfect Vision, which will allow B&L to offer surgeons the complete ‘all laser’ refractive solution.
The company also launched the Crystalens HD accommodating IOL and the Advanced Control Eye Tracking (ACE) technology for its Zyoptix refractive platform, which, according to B&L, compensates for static rotational movement and pupil shift for improved accuracy and predictability.
The Crystalens HD, the successor to the Crystalens Five-O, gained CE mark approval in August and was showcased to Europe for the first time at the congress. This initial launch will be followed by a full-scale rollout, expected in the second quarter of 2009.
To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Evaluating the clinical performance of ZEISS AT ELANA and the new ’ELISA’* approach
August 2nd 2025In this insightful analysis, Dr. Joong Hun Kim presents real-world clinical outcomes with bilateral implantation of ZEISS AT ELANA 841P. Dr. Kim recommends AT ELANA® 841P as an excellent option for patients undergoing cataract surgery as its fully trifocal optical design translates into a full range of vision. He also introduces the so-called ‘ELISA’ approach for patients requiring astigmatic correction in one eye only, combining AT ELANA 841P and ZEISS AT LISA tri toric 939MP. Early objective and subjective clinical data from this novel approach reveal promising visual outcomes and high patient satisfaction
